Nasal nitric oxide screening for primary ciliary dyskinesia: Systematic review and meta-analysis

European Respiratory Journal

Volumn 44, Issue 6, 2014, Pages 1589-1599

  Collins, Samuel A ^a,b   Gove, Kerry ^a,b   Walker, Woolf ^a,b   Lucas, Jane S A ^a,b  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ARTICLE; BREATH HOLDING; BREATHING; BRONCHIECTASIS; CHEMILUMINESCENCE IMMUNOASSAY KIT; CHILD; CHILD HEALTH; CILIARY DYSKINESIA; CYSTIC FIBROSIS; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FORCED EXPIRATION; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; NASAL HUMMING; NASAL NITRIC OXIDE ANALYZER; NITRIC OXIDE ANALYZER; NON INVASIVE PROCEDURE; OUTCOME ASSESSMENT; PATIENT SELECTION; PORTABLE EQUIPMENT; RESPIRATORY FUNCTION; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SOFT PALATE; SYSTEMATIC REVIEW; TIDAL BREATHING; ADOLESCENT; ADULT; BREATH ANALYSIS; KARTAGENER SYNDROME; MASS SCREENING; NOSE CAVITY; PRESCHOOL CHILD; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; BREATH TESTS; CHILD; CHILD, PRESCHOOL; HUMANS; KARTAGENER SYNDROME; MASS SCREENING; NASAL CAVITY; NITRIC OXIDE; YOUNG ADULT;

EID: 84916216961     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00088614     Document Type: Article

References (45)

1. Lucas JSA, Walker WT, Kuehni CE, et al. Primary ciliary dyskinesia. In: Courdier J-F, ed. Orphan Lung Diseases. Eur Respir Monogr 2011; 54: 201-217.
2. Barbato A, Frischer T, Kuehni CE, et al. Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur Respir J 2009; 34: 1264-1276.
3. Kuehni CE, Frischer T, Strippoli M-PF, et al. Factors influencing age at diagnosis of primary ciliary dyskinesia in European children. Eur Respir J 2010; 36: 1248-1258.
4. Strippoli M-PF, Frischer T, Barbato A, et al. Management of primary ciliary dyskinesia in European children: recommendations and clinical practice. Eur Respir J 2012; 39: 1482-1491.
5. Lundberg JO, Weitzberg E, Nordvall SL, et al. Primarily nasal origin of exhaled nitric oxide and absence in Kartagener's syndrome. Eur Respir J 1994; 7: 1501-1504.
6. Karadag B, James AJ, Gültekin E, et al. Nasal and lower airway level of nitric oxide in children with primary ciliary dyskinesia. Eur Respir J 1999; 13: 1402-1405.
7. Narang I, Ersu R, Wilson NM, et al. Nitric oxide in chronic airway inflammation in children: diagnostic use and pathophysiological significance. Thorax 2002; 57: 586-589.
8. Horváth I, Loukides S, Wodehouse T, et al. Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia. Thorax 2003; 58: 68-72.
9. Wodehouse T, Kharitonov SA, Mackay IS, et al. Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia. Eur Respir J 2003; 21: 43-47.
10. Corbelli R, Bringolf-Isler B, Amacher A, et al. Nasal nitric oxide measurements to screen children for primary ciliary dyskinesia. Chest 2004; 126: 1054-1059.
11. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171: 912-930.
12. Walker WT, Jackson CL, Lackie PM, et al. Nitric oxide in primary ciliary dyskinesia. Eur Respir J 2012; 40: 1024-1032.
13. Degano B, Valmary S, Serrano E, et al. Expression of nitric oxide synthases in primary ciliary dyskinesia. Hum Pathol 2011; 42: 1855-1861.
14. Smith CM, Kulkarni H, Radhakrishnan P, et al. Ciliary dyskinesia is an early feature of respiratory syncytial virus infection. Eur Respir J 2013; 43: 485-496.
15. Walker WT, Jackson CL, Coles J, et al. Ciliated cultures from patients with primary ciliary dyskinesia produce nitric oxide in response to Haemophilus influenzae infection and proinflammatory cytokines. Chest 2014; 145: 668-669.
16. Pifferi M, Bush A, Caramella D, et al. Agenesis of paranasal sinuses and nasal nitric oxide in primary ciliary dyskinesia. Eur Respir J 2011; 37: 566-571.
17. Marthin JK, Nielsen KG. Hand-held tidal breathing nasal nitric oxide measurement - a promising targeted casefinding tool for the diagnosis of primary ciliary dyskinesia. PLoS One 2013; 8: e57262.
18. Pizzimenti S, Bugiani M, Piccioni P, et al. Exhaled nitric oxide measurements: correction equation to compare hand-held device to stationary analyzer. Respir Med 2008; 102: 1272-1275.
19. Leigh MW, Hazucha MJ, Chawla KK, et al. Standardizing nasal nitric oxide measurement as a test for primary ciliary dyskinesia. Ann Am Thorac Soc 2013; 10: 574-581.
20. Csoma Z, Bush A, Wilson NM, et al. Nitric oxide metabolites are not reduced in exhaled breath condensate of patients with primary ciliary dyskinesia. Chest 2003; 124: 633-638.
21. Noone PG, Leigh MW, Sannuti A, et al. Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med 2004; 169: 459-467.
22. Piacentini GL, Bodini A, Peroni D, et al. Nasal nitric oxide for early diagnosis of primary ciliary dyskinesia: practical issues in children. Respir Med 2008; 102: 541-547.
23. Shoemark A, Wilson R. Bronchial and peripheral airway nitric oxide in primary ciliary dyskinesia and bronchiectasis. Respir Med 2009; 103: 700-706.
24. Moreno Galdó A, Vizmanos Lamotte G, Reverte Bover C, et al. Valor del ó xido nitrico nasal en el diagnó stico de la discinesia ciliar primaria [Value of nasal nitric oxide in the diagnosis of primary ciliary dyskinesia]. An Pediatr (Barc) 2010; 73: 88-93.
25. Marthin JK, Nielsen KG. Choice of nasal nitric oxide technique as first-line test for primary ciliary dyskinesia. Eur Respir J 2011; 37: 559-565.
26. Mateos-Corral D, Coombs R, Grasemann H, et al. Diagnostic value of nasal nitric oxide measured with non-velum closure techniques for children with primary ciliary dyskinesia. J Pediatr 2011; 159: 420-424.
27. Whiting P, Rutjes AWS, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3: 25.
28. Harrison M, Barry J, Burke L, et al. The clinical utility of a hand-held nasal nitric oxide (NNO) electrochemical analyser to screen patients with bronchiectasis for primary ciliary dyskinesia (PCD) and cystic fibrosis (CF). Irish J Med Sci 2012; 181: Suppl. 10, S403-S404.
29. Santamaria F, De Stefano S, Montella S, et al. Nasal nitric oxide assessment in primary ciliary dyskinesia using aspiration, exhalation, and humming. Med Sci Monit 2008; 14: CR80-CR85.
30. Walker WT, Liew A, Harris A, et al. Upper and lower airway nitric oxide levels in primary ciliary dyskinesia, cystic fibrosis and asthma. Respir Med 2013; 107: 380-386.
31. Boon M, Meyts I, Proesmans M, et al. Diagnostic accuracy of nitric oxide measurements to detect primary ciliary dyskinesia. Eur J Clin Invest 2014; 44: 477-485.
32. Harris A, Bhullar E, Gove K, et al. Validation of a portable nitric oxide analyzer for screening in primary ciliary dyskinesias. BMC Pulm Med 2014; 14: 18.
33. Pifferi M, Bush A, Maggi F, et al. Nasal nitric oxide and nitric oxide synthase expression in primary ciliary dyskinesia. Eur Respir J 2011; 37: 572-577.
34. Pifferi M, Caramella D, Cangiotti AM, et al. Nasal nitric oxide in atypical primary ciliary dyskinesia. Chest 2007; 131: 870-873.
35. Knowles MR, Ostrowski LE, Leigh MW, et al. Mutations in RSPH1 cause primary ciliary dyskinesia with a unique clinical and ciliary phenotype. Am J Respir Crit Care Med 2014; 189: 707-717.
36. Kott E, Legendre M, Copin B, et al. Loss-of-function mutations in RSPH1 cause primary ciliary dyskinesia with central-complex and radial-spoke defects. Am J Hum Genet 2013; 93: 561-570.
37. Piacentini GL, Bodini A, Peroni DG, et al. Nasal nitric oxide levels in healthy pre-school children. Pediatr Allergy Immunol 2010; 21: 1139-1145.
38. Montella S, Alving K, Maniscalco M, et al. Measurement of nasal nitric oxide by hand-held and stationary devices. Eur J Clin Invest 2011; 41: 1063-1070.
39. Maniscalco M, Weitzberg E, Sundberg J, et al. Assessment of nasal and sinus nitric oxide output using single-breath humming exhalations. Eur Respir J 2003; 22: 323-329.
40. Baraldi E, Pasquale MF, Cangiotti AM, et al. Nasal nitric oxide is low early in life: case study of two infants with primary ciliary dyskinesia. Eur Respir J 2004; 24: 881-883.
41. Stehling F, Roll C, Ratjen F, et al. Nasal nitric oxide to diagnose primary ciliary dyskinesia in newborns. Arch Dis Child Fetal Neonatal Ed 2006; 91: F233.
42. Baker BR, Chawla KK, Hazucha M, et al. Toward standardization of nasal nitric oxide testing for primary ciliary dyskinesia. Am J Respir Crit Care Med 2011; 183: A1210.
43. Moeller A, Horak F Jr, Lane C, et al. Inducible NO synthase expression is low in airway epithelium from young children with cystic fibrosis. Thorax 2006; 61: 514-520.
44. Grasemann H, Schwiertz R, Grasemann C, et al. Decreased systemic bioavailability of L-arginine in patients with cystic fibrosis. Respir Res 2006; 7: 87.
45. Struben VMD, Wieringa MH, Mantingh CJ, et al. Nasal NO: normal values in children age 6 through to 17 years. Eur Respir J 2005; 26: 453-457.